S100A15: zwischen angeborener Immunität und Differenzierung

• Applicant: Dr. Amanda Swantje Büchau
• Subject Area: Dermatology
• Term: from 2006 to 2009
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 29919151

• Final Report Year: 2009

Final Report Abstract

No abstract available

Publications

• Human S100A15 is regulated by calcium, cytokines, and bacterial compounds. 67th SID, May 3-6 2006, Philadelphia, Pennsylvania, USA
  
  
• Human S100A15 splice variants are differently expresses in inflammatory skin diseases and regulated through Th1i cytokines and calcium. Exp Dermatol 16:685-691, 2007
  Wolf R, Lewerenz V, Büchau AS, Walz M, Ruzicka T
  
• Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin-D-dependent mechanism. J Clin Invest 117:803-11, 2007
  Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL
  
• Innate immunity and antimicrobial defence systems in psoriasis. Clin Dermatol 25:616-624, 2007
  Büchau AS, Gallo RL
  
• Pimecrolimus enhances innate immune function of normal human keratinocytes. 68th SID, May 9-12 2007, Los Angeles, California, USA
  
  
• S100A15, an antimicrobial protein of the skin: regulation by E coli through Toll-like receptor 4. J Invest Dermatol 127:2596-604, 2007
  Büchau AS, Hassan M, Kukova G, Lewerenz V, Würthner JU, Wolf R, Walz M, Ruzicka T
  
• Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol. 128:816-24,2008
  Schauber J, Oda Y, Büchau AS, Yun QY, Steinmeyer A, Zügel U, Bikle DD, Gallo RL
  
• Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes. J Invest Dermatol. 128:2646-54, 2008
  Büchau AS, Schauber J, Hultsch T, Stuetz A, Gallo RL